Difficulty: Medium
Average Score: 86%
Practice
NMDA receptor antagonist is frequently used for a patient with AD who is experiencing decreased memory and cognition?
Correct answer
D
Rationale
The correct answer is D) Memantine (Namenda). Memantine is an NMDA receptor antagonist commonly used in the treatment of Alzheimer's disease (AD) to help improve memory and cognition. NMDA receptors play a crucial role in learning and memory processes, and by antagonizing these receptors, memantine helps regulate glutamate activity in the brain, which is beneficial for patients experiencing cognitive decline in AD.
A) Trazodone (Desyrel) is an antidepressant that primarily acts on serotonin receptors and is not indicated for improving memory or cognition in AD patients.
B) Olanzapine (Zyprexa) is an antipsychotic medication used to treat symptoms like hallucinations or delusions in conditions like schizophrenia or bipolar disorder. It is not used to target memory and cognition deficits in AD.
C) Rivastigmine (Exelon) is a cholinesterase inhibitor, which works by increasing levels of acetylcholine in the brain to help with cognitive symptoms in AD. While it is a common treatment for AD, it does not target NMDA receptors like memantine does.
Educationally, understanding the mechanisms of action of different medications used in treating neurological conditions is crucial for healthcare professionals to make informed decisions when managing patients with cognitive impairments. Knowing the specific roles of medications like memantine, rivastigmine, and others can help tailor treatment plans to individual patient needs and optimize therapeutic outcomes.
A) Trazodone (Desyrel) is an antidepressant that primarily acts on serotonin receptors and is not indicated for improving memory or cognition in AD patients.
B) Olanzapine (Zyprexa) is an antipsychotic medication used to treat symptoms like hallucinations or delusions in conditions like schizophrenia or bipolar disorder. It is not used to target memory and cognition deficits in AD.
C) Rivastigmine (Exelon) is a cholinesterase inhibitor, which works by increasing levels of acetylcholine in the brain to help with cognitive symptoms in AD. While it is a common treatment for AD, it does not target NMDA receptors like memantine does.
Educationally, understanding the mechanisms of action of different medications used in treating neurological conditions is crucial for healthcare professionals to make informed decisions when managing patients with cognitive impairments. Knowing the specific roles of medications like memantine, rivastigmine, and others can help tailor treatment plans to individual patient needs and optimize therapeutic outcomes.